Studies over the last few years have made it increasingly clear that depression & anxiety are highly prevalent in individuals with CF as well as their parent caregivers. Clinical care guidelines for preventing, screening & treating anxiety & depression have been developed & submitted for publication. This session will provide an opportunity to hear strategies of successful guideline implemention.
Define prevalence of anxiety & depression in the CF population.
Describe successful methods for implementing anxiety & depression screening & treatment in CF care centers.
Assess patient outcomes in anxiety & depression screening.